Search hospitals > North Carolina > Pinehurst
FirstHealth of the Carolinas
Claim this profilePinehurst, North Carolina 28374
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Endometrial Cancer
Conducts research for Breast Cancer
Conducts research for Endometrial Adenocarcinoma
17 reported clinical trials
2 medical researchers
Summary
FirstHealth of the Carolinas is a medical facility located in Pinehurst, North Carolina. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Endometrial Cancer, Breast Cancer, Endometrial Adenocarcinoma and other specialties. FirstHealth of the Carolinas is involved with conducting 17 clinical trials across 33 conditions. There are 2 research doctors associated with this hospital, such as Charles S. Kuzma and Michael J. Sundborg, MD.Area of expertise
1Lung Cancer
Stage IV
Stage III
metastatic
2Non-Small Cell Lung Cancer
Stage IV
Stage III
MET positive
Top PIs
Charles S. KuzmaFirstHealth of the Carolinas-Moore Regional Hospital6 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
53 reported clinical trials
112 drugs studied
Michael J. Sundborg, MDFirstHealth Outpatient Cancer Center5 years of reported clinical research
Studies Cervical Cancer
Studies Fallopian Tube Cancer
4 reported clinical trials
10 drugs studied
Clinical Trials running at FirstHealth of the Carolinas
Lung Cancer
Non-Small Cell Lung Cancer
Endometrial Cancer
Follicular Lymphoma
Colorectal Cancer
Cancer
Parkinson's disease
Endometrial Adenocarcinoma
Non-Hodgkin's Lymphoma
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
JNJ-90301900 + Chemoradiation
for Lung Cancer
The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can improve objective response rate (ORR; that is percentage of participants whose best response is complete response or partial response during the study) in participants with locally advanced and unresectable stage III non-small cell lung cancer.
Recruiting1 award Phase 23 criteria
Tolododekin Alfa + Cetrelimab
for Non-Small Cell Lung Cancer
A study of tolododekin alfa (also known as ANK-101) administered in combination with an anti-programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) antibody in participants with advanced or metastatic non-small cell lung cancer (NSCLC). Cohort A will enroll participants who have progressed on prior standard of care treatment with an anti-PD-1/PD-L1 antibody and a platinum-based chemotherapy regimen. Cohort B will enroll participants who are treatment-naïve for locally advanced or metastatic NSCLC.
Recruiting1 award Phase 15 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at FirstHealth of the Carolinas?
FirstHealth of the Carolinas is a medical facility located in Pinehurst, North Carolina. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Endometrial Cancer, Breast Cancer, Endometrial Adenocarcinoma and other specialties. FirstHealth of the Carolinas is involved with conducting 17 clinical trials across 33 conditions. There are 2 research doctors associated with this hospital, such as Charles S. Kuzma and Michael J. Sundborg, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.